Interpreting Pharmaceutical Particle Characterization Data: A Practical Guide to Results, Uncertainty, and Defensible Conclusions

Pharmaceutical particle investigations do not end when an instrument produces an image, spectrum, or elemental table. The real challenge is interpreting the evidence correctly: understanding what the method measured, recognizing uncertainty, distinguishing observation from inference, and explaining how the results support a quality decision. This article focuses on pharmaceutical particle characterization data interpretation—a practical angle distinct from introductory guides to particle types and analytical techniques.

Why data interpretation matters in particle characterization

An analytical result is meaningful only when considered in the context of the sample, method, preparation, controls, and investigation question. A particle may produce an elemental spectrum containing iron and chromium, for example, but that result alone does not prove which equipment component generated it. Several materials may share elements, and the substrate or sample preparation may contribute signals.

Good interpretation therefore answers three separate questions: what was directly observed, what can reasonably be inferred, and what remains unconfirmed. Keeping these levels separate helps prevent overstatement and makes reports more useful to Quality Assurance (QA), Quality Control (QC), engineering, and manufacturing teams.

1. Begin with a clearly defined analytical question

Before reviewing results, confirm the question the investigation is intended to answer. Is the objective to describe a particle, identify its likely material class, compare it with a suspected source, measure its dimensions, or evaluate whether several particles may share a common origin? These are different questions and may require different evidence.

• Material identification: determine whether the evidence supports a material or chemical class.
• Source comparison: assess similarities and differences between the unknown particle and a representative candidate material.
• Size assessment: report dimensions using a defined measurement convention.
• Population assessment: describe the observed distribution only when sampling and counting methods support that conclusion.

A report should not claim to establish a source if the work was designed only to identify elemental composition.

2. Interpret microscopy images with measurement context

Optical microscopy and scanning electron microscopy (SEM) can reveal shape, edges, surface texture, fractures, and other morphological features. These observations can guide hypotheses, but morphology is rarely unique to one material or source.

When documenting size, state the dimension being reported. Maximum Feret diameter, minimum Feret diameter, equivalent circular diameter, and longest visible dimension are not interchangeable. Irregular particles may yield different values under different conventions. Reports should describe the measurement approach, image calibration, magnification or scale reference, and relevant limitations.

Image quality also matters. Poor contrast, particle overlap, focus, tilt, charging, coating, or an uneven substrate may affect what can be measured or interpreted. If the particle is partially obscured, report that limitation rather than implying that the observed dimension represents its complete size.

3. Read SEM-EDS results without overclaiming

Energy-dispersive X-ray spectroscopy (EDS) identifies elements through characteristic X-ray signals generated during electron-beam interaction with a sample. It is valuable for investigating inorganic particles and many metal-containing fragments. However, EDS is elemental analysis, not a complete molecular fingerprint.

Interpretation should consider the spectrum, the locations analyzed, background and substrate contributions, particle geometry, acquisition conditions, and the software’s quantification assumptions. A spectrum from a small particle mounted on a membrane may include signals from the membrane or mounting material. Where relevant, blank-substrate measurements and suitable controls can help distinguish sample signals from background.

Elemental weight percentages are often semi-quantitative and depend on analytical conditions and sample characteristics. They should not automatically be treated as exact bulk composition. Low-level peaks should be evaluated in light of signal quality, possible overlaps, and the laboratory’s reporting criteria.

4. Use FTIR and other methods as complementary evidence

Fourier-transform infrared spectroscopy (FTIR) provides information about molecular vibrations and can help identify many polymers, fibers, and organic materials. A match to a reference library is stronger when the spectrum has adequate quality, relevant diagnostic bands, and a suitable reference spectrum. Mixtures, contamination, surface coatings, particle size, and sample preparation may complicate interpretation.

When SEM-EDS and FTIR are both used, the results should be integrated rather than forced into artificial agreement. EDS may show inorganic elements associated with a particle while FTIR detects an organic component, coating, or attached residue. The methods examine different properties and may sample different areas or volumes.

5. Evaluate uncertainty and method limitations

Every analytical method has limits. These may include detection capability, spatial resolution, calibration, repeatability, sample heterogeneity, preparation effects, and operator interpretation. The report should state limitations that could materially affect the conclusion.

Uncertainty does not make a result unusable. It helps define how strongly the evidence supports a statement. For example, an analyst may confidently report that a particle contains detectable iron and chromium, while describing a specific stainless-steel component as a possible source that requires further comparison.

6. Compare candidate sources systematically

Source attribution should be based on a structured comparison. Candidate sources might include process equipment, packaging components, closures, filters, tools, cleaning materials, or environmental sources. The appropriate candidates depend on the product, process flow, location of discovery, and investigation history.

Useful comparison factors may include elemental or molecular composition, morphology, dimensions, surface features, manufacturing context, and the plausibility of particle release. Reference samples should be representative of the actual candidate material. A generic material sample may not represent a particular alloy, coating, grade, or aged component.

Document both supporting and conflicting evidence. If two candidate sources have similar compositions, explain why the available evidence cannot distinguish them, or identify additional work that could help.

7. Separate facts, interpretations, and hypotheses in the report

A clear report uses language proportionate to the evidence:

• Observation: “The analyzed area showed detectable iron and chromium signals under the stated SEM-EDS conditions.”
• Interpretation: “The result is consistent with an iron- and chromium-containing material.”
• Hypothesis: “A stainless-steel component is one possible source and requires comparison with candidate materials and process records.”

This structure prevents a plausible hypothesis from being reported as a proven root cause. It also makes technical review more efficient because reviewers can see where data end and interpretation begins.

8. Build a transparent result table

For each particle or analytical site, consider recording the sample identifier, site identifier, imaging reference, measurement convention, measured dimensions, analytical method, key findings, and interpretation. When elemental composition is reported, state whether values are normalized and whether the result is qualitative or semi-quantitative. Link spectra and micrographs to the same particle or site wherever possible.

Do not combine results from different particles into a single average unless the scientific purpose and calculation are justified. An average can conceal meaningful differences between particles or sites. Similarly, a small number of analyzed particles should not be described as representative of the entire batch unless the sampling design supports that claim.

9. Connect the analytical conclusion to the quality investigation

Characterization results are one evidence stream within a wider deviation or contamination investigation. The quality team may also need to review batch history, manufacturing interventions, equipment maintenance, container and closure systems, environmental observations, prior events, and the distribution of affected units.

Analytical findings may help prioritize follow-up activities, but they do not independently determine batch disposition or patient risk. Those decisions belong to the authorized quality process and must consider the full body of evidence and applicable requirements.

10. Common interpretation errors to avoid

• Equating elemental detection with proof of a specific source.
• Reporting a particle dimension without defining the measurement convention.
• Ignoring substrate, mounting media, or sample-preparation contributions.
• Treating semi-quantitative EDS percentages as exact bulk composition.
• Calling a library match definitive without assessing spectral quality and alternatives.
• Generalizing from a few selected particles to an entire product population.
• Omitting conflicting evidence or method limitations.

Practical review checklist

Before approving a particle characterization report, verify that the investigation question is explicit; sample identity and traceability are clear; images and spectra are linked to the correct particle; dimensions are defined; controls and substrate effects are considered; results are reported with appropriate qualifiers; and source attribution is supported by comparative evidence. Confirm that the conclusion answers the original question without exceeding what the data can establish.

Frequently asked questions

Can SEM-EDS identify the exact source of a pharmaceutical particle?

No. It can provide elemental evidence, but exact source attribution usually requires comparison with candidate materials and supporting process evidence.

Why can two analysts report different particle sizes?

They may use different size descriptors, image thresholds, orientations, calibration settings, or approaches to irregular particle boundaries. The measurement convention should be defined and applied consistently.

Should EDS weight percentages be treated as exact values?

Not automatically. Quantification can be affected by sample geometry, substrate contributions, acquisition conditions, and other factors. The reporting basis and limitations should be stated.

When should a second analytical method be used?

When the initial method cannot answer the investigation question adequately, when results are ambiguous, or when an independent type of evidence would help distinguish candidate materials.

What makes a particle characterization conclusion defensible?

Traceable sample handling, suitable methods, transparent results, acknowledged limitations, consideration of alternatives, and conclusions proportionate to the evidence.

Conclusion

Reliable pharmaceutical particle characterization depends not only on sophisticated instrumentation but also on disciplined interpretation. Clear analytical questions, defined measurement conventions, attention to substrate effects, complementary methods, and transparent uncertainty statements help teams avoid unsupported conclusions.

For pharmaceutical QA and QC teams, a defensible report separates what was observed from what is inferred and what remains a hypothesis. This approach supports more focused root cause investigations and better-informed quality decisions.

Confianca Pharmazon supports pharmaceutical quality and contamination investigation needs. Contact the team to discuss particle characterization-related requirements and appropriate analytical support.

Technical note: This article is educational and does not replace current compendial requirements, validated laboratory procedures, or the quality unit’s assessment.